Noticias de REGN_US
Noticias del mercado
Últimas noticias sobre REGN_US — 312 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Regeneron Pharmaceuticals Releases Q1 2026 Financial Results
Regeneron basks in first gene therapy approval as Dupixent, Eylea carry robust Q1 earnings
Regeneron shares slide despite Q1 beat
Is Regeneron (REGN) Still 23.3% Undervalued After Q1 2026? Non-G
Regeneron Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:REGN) 2026-04-29
Regeneron tops Q1 estimates on Dupixent momentum
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock
Regeneron drops despite Q1 beat, $3B share buyback program
Regeneron Pharmaceuticals (REGN) Reports Strong Q1 Earnings with Share Buyback Announcement
Q1 2026 Regeneron Pharmaceuticals Inc Earnings Call Transcript
Regeneron Pharmaceuticals (REGN) Reports Strong Q1 Earnings with Share Buyback Announcement
Regeneron (REGN) Reports Strong Q1 Revenue and New Drug Pricing Initiative
Regeneron Pharmaceuticals Q1 Adjusted Earnings, Revenue Rise
Is Regeneron (REGN) Still 23.3% Undervalued After Q1 2026? Non-G
Regeneron beats first quarter estimates on Dupixent strength By Investing.com
Página 6 de 16
